Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

Spiriva® Assessment of FEV1 (SAFE)

NCT00277264 ·Status: COMPLETED ·Phase: PHASE3

Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

NCT00274014 ·Status: COMPLETED ·Phase: PHASE3

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

NCT00239408 ·Status: COMPLETED ·Phase: PHASE4

Special Survey Long-term Treatment With Tiotropium on COPD

NCT00638183 ·Status: COMPLETED

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

NCT00274053 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

NCT05161156 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

NCT02177318 ·Status: COMPLETED

SPIRIVA in Ususal Care

NCT00274079 ·Status: COMPLETED ·Phase: PHASE4

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

NCT00274027 ·Status: COMPLETED ·Phase: PHASE3

Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea

NCT00540163 ·Status: COMPLETED

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

NCT00274508 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03118765 ·Status: COMPLETED ·Phase: PHASE2

PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD

NCT01566773 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT05986591 ·Status: COMPLETED ·Phase: PHASE3

A Prescription-Event Monitoring (PEM) Study of Tiotropium

NCT02196194 ·Status: COMPLETED

Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients

NCT00620516 ·Status: COMPLETED

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

NCT00615992 ·Status: COMPLETED

A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions

NCT06487416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239499 ·Status: COMPLETED ·Phase: PHASE4

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00144326 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)

NCT06326671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

NCT00784550 ·Status: COMPLETED ·Phase: PHASE4

Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients

NCT00157235 ·Status: COMPLETED ·Phase: PHASE3

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

NCT02275481 ·Status: TERMINATED ·Phase: PHASE4